Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Ralinepag

EU orphan designation number: EU/3/18/2130   
Active ingredient: Ralinepag
Indication: Treatment of pulmonary arterial hypertension
Sponsor: Unither Therapeutik GmbH
Dreieichstrasse 11, 64546 Moerfelden-Walldorf, Deutschland

  

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
15/01/2019 Orphan designation EMA/OD/0000002037 (2019)239 of 11/01/2019
15/04/2019 Transfer of orphan designation EMA/OD/0000005929 (2019)2969 of 11/04/2019